Úc - Tiếng Anh - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - lignocaine hydrochloride; adrenaline tartrate - parenteral liquid/solution/suspension - lignocaine hydrochloride caine active 20.0 mg/ml; adrenaline tartrate hormone active 0.0182 mg/ml - anaesthetics/analgesics - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - anaesthetic - local/general | general anaesthetic | immobiliser | local anaesthetic | premedication | sedative | tranquilliser | travel sickness

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.0091 mg/ml equivalent to 5 µg/ml adrenaline;  ; lidocaine hydrochloride 10 mg/ml; adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]); lidocaine hydrochloride 10 mg/ml; adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]); lidocaine hydrochloride 10 mg/ml - solution for injection - active: adrenaline acid tartrate 0.0091 mg/ml equivalent to 5 µg/ml adrenaline   lidocaine hydrochloride 10 mg/ml excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]) lidocaine hydrochloride 10 mg/ml excipient: carbon dioxide hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]) lidocaine hydrochloride 10 mg/ml excipient: carbon dioxide hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.0091 mg/ml;  ; lidocaine hydrochloride 20 mg/ml; adrenaline acid tartrate 0.0091 mg/ml; lidocaine hydrochloride 20 mg/ml - solution for injection - active: adrenaline acid tartrate 0.0091 mg/ml   lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 0.0227 mg/ml equivalent to 12.5 µg/ml adrenaline; lidocaine hydrochloride 20 mg/ml;  ;   - solution for injection - active: adrenaline acid tartrate 0.0227 mg/ml equivalent to 12.5 µg/ml adrenaline lidocaine hydrochloride 20 mg/ml     excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

lignocaine hydrochloride; adrenaline acid tartrate; adrenaline -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; sodium metabisulfite; water for injections - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 17 july 2003 : lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 53.3 mg (equivalent: lidocaine hydrochloride, qty 50 mg) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 213.2 mg (equivalent: lidocaine hydrochloride, qty 200 mg) - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - lidocaine hydrochloride monohydrate, quantity: 42.66 mg (equivalent: lidocaine hydrochloride, qty 40 mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydrochloric acid - for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.